Emergency Contraceptives Market Size and Growth Rate:

“The Global Emergency Contraceptives Market is expected to reach US$ xx Mn by 2023 owing to growth in R&D for the development of contraceptive”

Emergency Contraceptives Market Growth Drivers and Restraints:

The global emergency contraceptive market is expected to reach US$ xx Mn by 2023. Emergency contraception is a way to prevent pregnancy after unprotected sex. The major factors which are driving the growth of global emergency contraceptive market are increasing number of unplanned pregnancy across the globe and increasing government support for the promotion of emergency contraceptive to create awareness among the people. These emergency contraceptive also help the cases of sexual assault from their unwanted pregnancies. The use of effective contraceptive can prevent abortion-related and pregnancy-related morbidity and mortality cases in developing regions. Moreover, the easy access to contraceptives and voluntarily family planning has also contributed in the growth of global emergency contraceptive market. On the flip side lack awareness of about these emergency contraceptive in rural areas and side effect associated with the frequent usage of these hamper the global emergency contraceptive market growth. The World Health Organization (WHO) lists no medical condition for which the risks associated with the use of emergency contraceptive outweigh the benefits.

Browse More Details of the report @ https://www.precisionbusinessinsights.com/market-reports/global-emergency-contraceptives-market/

Antiprogestin Dominate the Global Emergency Contraceptives Market

Based on the product type, global emergency contraceptive market is segmented into combined, antiprogestin, and progestin only. Antiprogestin dominates the global emergency contraceptive market owing to its minimal side effects, more effectiveness, and lesser dosage compared to other. For instance, the antiprogestin ulipristal acetate which is available as a micronized emergency contraceptive tablet is effective up to 120 hours after intercourse.

North America Leads the Global Emergency Contraceptives Market

PBI’s global emergency contraceptive market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global emergency contraceptive market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in their research and development, continuous government support, disposable income and healthcare expenditure. Additionally, the presence of key market players over there are also contributing in the growth of global emergency contraceptive market. Asia Pacific emergency contraceptive market is expected to grow at a significant rate due to their continuous increase in population majorly in India and China. Moreover, emerging economies, construction of new pharmaceutical plants, rising government initiatives to create awareness, and technological advancements helps in the growth of emergency contraceptive market in APAC region.
Launch of newer products, and strategic alliances are the key strategies adopted by market players

Global Emergency Contraceptive market further reveals that the key player’s increasingly adopting strategies such as launch of newer products, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.
For instance, in July 2018, Vagisil launched “Preventeza” an emergency contraceptives pill. Also, they are giving free product via the launch of its “Buy One Get One or Give One (BoGoGo)” product campaign where women who purchase Preventeza on Vagisil.com will have the option to get a second one for free to either keep on hand or to give to another woman in their life.

Key player’s profiles in the report are Lupin, Bayer AG, Teva Pharmaceutical Industries Ltd., Mankind Pharma Ltd., Piramal Enterprises Limited, Vagisil, HRA Pharma, Pfizer, Sun Pharmaceutical Industries, Richter Gedeon Nyrt, and Zhejiang Xianju Pharmaceutical Co.

Avail Sample of the report @ https://www.precisionbusinessinsights.com/request-sample?product_id=15848

Detailed Segmentation of Emergency Contraceptives Market:

By Product Type
• Combined (Estrogen and Progestin)
• Progestin-only
• Antiprogestin

By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
• Others

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights